ConductScience.org, home

Paper39488790

Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer.

Jiang X and 19 others. Adv Sci (Weinh), 2024. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer. Papers, record 39488790. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39488790

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer.
PubMed
Journal
Adv Sci (Weinh)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.54, provisional
iCite
Revised in PubMed
2026-03-04
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jiang XXingyuhttps://orcid.org/0009-0008-3043-819X
2Yang MMuwen
3Zhang WWeijing
4Shi DDongni
5Li YYue
6He LLixin
7Huang SShumei
8Chen BBoyu
9Chen XXuwei
10Kong LLingzhi
11Pan YYibing
12Deng PPinwei
13Wang RRui
14Ouyang YYing
15Chen XXiangfu
16Li JJun
17Li ZZheng
18Zou HHequn
19Zhang YYanna
20Song LLibinghttps://orcid.org/0000-0002-5315-771X

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Ovarian EpithelialMajor topic
Drug Resistance, NeoplasmMajor topic
Neoplastic Stem CellsMajor topic
Ovarian NeoplasmsMajor topic
Myosin Heavy ChainsMajor topic
Humans
Female
Mice
Cell Line, Tumor
Animals
Wnt Signaling Pathway
Platinum
Antineoplastic Agents
Disease Models, Animal

Source PubMed

Download CSV of topics

Grants17

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2020YFA0509400National Key Research and Development Program of ChinaPubMed
2023A1515012746Natural Science Foundation of Guangdong ProvincePubMed
2021A1515012476Natural Science Foundation of Guangdong ProvincePubMed
2021A1515010333Natural Science Foundation of Guangdong ProvincePubMed
2023M734041China Postdoctoral Science FoundationPubMed
BX20230441China Postdoctoral Innovation Talent Support ProgramPubMed
2023A1515110871Basic and Applied Basic Research Foundation of Guangdong ProvincePubMed
A2303050Shenzhen Medical Research FundsPubMed
81530082National Natural Science Foundation of ChinaPubMed
82373369National Natural Science Foundation of ChinaPubMed
82173302National Natural Science Foundation of ChinaPubMed
82030078National Natural Science Foundation of ChinaPubMed
82330082National Natural Science Foundation of ChinaPubMed
82203113National Natural Science Foundation of ChinaPubMed
82303157National Natural Science Foundation of ChinaPubMed
82171955National Natural Science Foundation of ChinaPubMed
81902675National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117567956Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells.Mol Biol Cell2007https://conductscience.org/library/papers/17567956PubMed
224096485Targeting cancer stem cells to suppress acquired chemotherapy resistance.Oncogene2014https://conductscience.org/library/papers/24096485PubMed
323369605Mechanisms of chemoresistance in cancer stem cells.Clin Transl Med2013https://conductscience.org/library/papers/23369605PubMed
436147467SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway.Int J Biol Sci2022https://conductscience.org/library/papers/36147467PubMed
528323021The challenge of targeting cancer stem cells to halt metastasis.Semin Cancer Biol2017https://conductscience.org/library/papers/28323021PubMed
622204725A phase 3 trial of bevacizumab in ovarian cancer.N Engl J Med2011https://conductscience.org/library/papers/22204725PubMed
738527625Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research.Adv Drug Deliv Rev2024https://conductscience.org/library/papers/38527625PubMed
835205721Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.Cancers (Basel)2022https://conductscience.org/library/papers/35205721PubMed
932296030Targeting cancer stem cell pathways for cancer therapy.Signal Transduct Target Ther2020https://conductscience.org/library/papers/32296030PubMed
1031245788Metabolic signatures of cancer cells and stem cells.Nat Metab2019https://conductscience.org/library/papers/31245788PubMed
1129432994SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.Biomed Pharmacother2018https://conductscience.org/library/papers/29432994PubMed
1238572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1327322403The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses.Curr Protoc Bioinformatics2016https://conductscience.org/library/papers/27322403PubMed
1433589595Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.Signal Transduct Target Ther2021https://conductscience.org/library/papers/33589595PubMed
1532791150Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA.Life Sci2020https://conductscience.org/library/papers/32791150PubMed
1630862442Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?Immunol Lett2019https://conductscience.org/library/papers/30862442PubMed
1725481791Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.Lancet Oncol2015https://conductscience.org/library/papers/25481791PubMed
1827898521Pathogenesis and heterogeneity of ovarian cancer.Curr Opin Obstet Gynecol2017https://conductscience.org/library/papers/27898521PubMed
1915865432Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylation.Biochemistry2005https://conductscience.org/library/papers/15865432PubMed
2037059592Cellular senescence-related gene signature as a valuable predictor of prognosis in hepatocellular carcinoma.Aging (Albany NY)2023https://conductscience.org/library/papers/37059592PubMed

See all 63 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42948403Discovery of a small molecule RIOK1 inhibitor CINS-1 against colorectal cancer via disrupting ribosomal biosynthesis.Acta Pharm Sin B2026https://conductscience.org/library/papers/42948403PubMed
42220495The enigmatic role of tumor dormancy cells in gynecologic cancers.Front Immunol2026https://conductscience.org/library/papers/42220495PubMed
42212330
Biomembrane-coated Nanoparticles Targeting circHIF1α Suppress Ovarian Cancer Metastasis and Cisplatin Resistance by Mediating System Xc⁻ Inactivation via SLC7A11/SLC3A2 to Induce Ferroptosis in Cancer Stem Cells.
Int J Biol Sci2026https://conductscience.org/library/papers/42212330PubMed
41940421Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway.Clin Transl Med2026https://conductscience.org/library/papers/41940421PubMed
41801295A plant alkaloid lycorine inhibits non-small cell lung cancer cell proliferation, metastasis, glycolysis and promotes ferroptosis through the ZNF143/SPC25 axis.J Nat Med2026https://conductscience.org/library/papers/41801295PubMed
41673219BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer.Sci Rep2026https://conductscience.org/library/papers/41673219PubMed
41376855Platinum-resistant ovarian cancer: From mechanisms to treatment strategies.Genes Dis2026https://conductscience.org/library/papers/41376855PubMed
41375045Integrating Functional Genomic Screens and Multi-Omics Data to Construct a Prognostic Model for Lung Adenocarcinoma and Validating SPC25.Cancers (Basel)2025https://conductscience.org/library/papers/41375045PubMed
41345704Lactylation-driven KRT19 promotes non-small cell lung cancer progression by suppressing cellular senescence.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/41345704PubMed
40400636The multifaceted functions of SPC25 in cancer: from molecular pathways to targeted therapy.Front Med (Lausanne)2025https://conductscience.org/library/papers/40400636PubMed
39488790Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer.Adv Sci (Weinh)2024https://conductscience.org/library/papers/39488790PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
MYH94627PubTator's text mininghttps://conductscience.org/library/genes/4627NCBI Gene
RIOK183732PubTator's text mininghttps://conductscience.org/library/genes/83732NCBI Gene
SERPINH1871PubTator's text mininghttps://conductscience.org/library/genes/871NCBI Gene
SPC2557405PubTator's text mininghttps://conductscience.org/library/genes/57405NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39488790

GET https://conductscience.org/api/papers/v1/39488790/references?page=2